Furthermore, drugs targeting several amino acid metabolisms have been shown to inhibit the growth and invasion of colorectal cancer cells, for instance, the glutaminase inhibitor, CB-839, could enhance the antitumor activity of capecitabine and cetuximab (Cohen et al., 2020; Zhao et al., 2020). This evidence concerns the gene GLS and colorectal cancer.